Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase

被引:84
作者
Kass, Elizabeth M. [1 ]
Helgadottir, Hildur R. [1 ,2 ]
Chen, Chun-Chin [1 ,2 ]
Barbera, Maria [1 ]
Wang, Raymond [1 ]
Westermark, Ulrica K. [1 ]
Ludwig, Thomas [4 ]
Moynahan, Mary Ellen [3 ]
Jasin, Maria [1 ,2 ]
机构
[1] Cornell Univ, Dev Biol Program, New York, NY 10065 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[4] Ohio State Univ, Wexner Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
DNA-DAMAGE; DIRECTED REPAIR; EMBRYONIC LETHALITY; TUMOR SUPPRESSION; IN-VIVO; PROTEIN; MICE; GENOME; MODEL; IDENTIFICATION;
D O I
10.1073/pnas.1216824110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Homology-directed repair (HDR) is a critical pathway for the repair of DNA double-strand breaks (DSBs) in mammalian cells. Efficient HDR is thought to be crucial for maintenance of genomic integrity during organismal development and tumor suppression. However, most mammalian HDR studies have focused on transformed and immortalized cell lines. We report here the generation of a Direct Repeat (DR)-GFP reporter-based mouse model to study HDR in primary cell types derived from diverse lineages. Embryonic and adult fibroblasts from these mice as well as cells derived from mammary epithelium, ovary, and neonatal brain were observed to undergo HDR at I-SceI endonuclease-induced DSBs at similar frequencies. When the DR-GFP reporter was crossed into mice carrying a hypomorphic mutation in the breast cancer susceptibility gene Brca1, a significant reduction in HDR was detected, showing that BRCA1 is critical for HDR in somatic cell types. Consistent with an HDR defect, Brca1 mutant mice are highly sensitive to the cross-linking agent mitomycin C. By contrast, loss of the DSB signaling ataxia telangiectasia-mutated (ATM) kinase did not significantly alter HDR levels, indicating that ATM is dispensable for HDR. Notably, chemical inhibition of ATM interfered with HDR. The DR-GFP mouse provides a powerful tool for dissecting the genetic requirements of HDR in a diverse array of somatic cell types in a normal, nontransformed cellular milieu.
引用
收藏
页码:5564 / 5569
页数:6
相关论文
共 58 条
  • [31] HIGH SPONTANEOUS INTRACHROMOSOMAL RECOMBINATION RATES IN ATAXIA-TELANGIECTASIA
    MEYN, MS
    [J]. SCIENCE, 1993, 260 (5112) : 1327 - 1330
  • [32] Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
    Mikkers, H
    Nawijn, M
    Allen, J
    Brouwers, C
    Verhoeven, E
    Jonkers, J
    Berns, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) : 6104 - 6115
  • [33] DNA end resection: Many nucleases make light work
    Mimitou, Eleni P.
    Symington, Lorraine S.
    [J]. DNA REPAIR, 2009, 8 (09) : 983 - 995
  • [34] The controlling role of ATM in homologous recombinational repair of DNA damage
    Morrison, C
    Sonoda, E
    Takao, N
    Shinohara, A
    Yamamoto, K
    Takeda, S
    [J]. EMBO JOURNAL, 2000, 19 (03) : 463 - 471
  • [35] Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
    Moynahan, Mary Ellen
    Jasin, Maria
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (03) : 196 - 207
  • [36] BRCA2 is required for homology-directed repair of chromosomal breaks
    Moynahan, ME
    Pierce, AJ
    Jasin, M
    [J]. MOLECULAR CELL, 2001, 7 (02) : 263 - 272
  • [37] A model for testing recombinogenic sequences in the mouse germline
    Moynahan, ME
    Akgun, E
    Jasin, M
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (07) : 875 - 886
  • [38] Brca1 controls homology-directed DNA repair
    Moynahan, ME
    Chiu, JW
    Koller, BH
    Jasin, M
    [J]. MOLECULAR CELL, 1999, 4 (04) : 511 - 518
  • [39] The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
    Moynahan, ME
    [J]. ONCOGENE, 2002, 21 (58) : 8994 - 9007
  • [40] Moynahan ME, 2001, CANCER RES, V61, P4842